Scarica l'app Stockscreener
0.4655
0.70%
-0.0033
Dopo l'orario di chiusura:
.46
-0.0055
-1.18%
Precedente Chiudi:
$0.4688
Aprire:
$0.49
Volume 24 ore:
294.92K
Relative Volume:
0.45
Capitalizzazione di mercato:
$4.23M
Reddito:
$852.30K
Utile/perdita netta:
$-21.37M
Rapporto P/E:
-0.0215
EPS:
-21.6981
Flusso di cassa netto:
$-19.06M
1 W Prestazione:
-8.15%
1M Prestazione:
-38.26%
6M Prestazione:
-75.88%
1 anno Prestazione:
-97.30%
Intervallo 1D:
$0.4602
$0.49
Intervallo di 1 settimana:
$0.4499
$0.53
Portata 52W:
$0.4499
$18.20
Geovax Labs Inc Stock (GOVX) Company Profile
Nome
Geovax Labs Inc
Settore
Industria
Telefono
678-384-7220
Indirizzo
1955 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.4655 | 4.26M | 852.30K | -21.37M | -19.06M | -21.70 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Downgrade | D. Boral Capital | Buy → Hold |
| 2025-04-15 | Reiterato | Alliance Global Partners | Buy |
| 2025-04-15 | Reiterato | D. Boral Capital | Buy |
| 2024-11-11 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-16 | Iniziato | ROTH MKM | Buy |
| 2020-11-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Geovax Labs Inc Borsa (GOVX) Ultime notizie
GeoVax provides Nasdaq hearing update, plans to present compliance plan and advance GEO-MVA Phase 3 - TradingView
GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities - TradingView
GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits
GeoVax Welcomes Global Mpox Vaccine Stockpile, Highlights GEO-MVA's Role in Diversifying Supply - citybuzz -
GeoVax Welcomes Launch of Global Mpox Vaccine Stockpile, Highlights GEO-MVA Readiness to Support Diversified Global Supply - TradingView
GeoVax (NASDAQ: GOVX) plans reverse split after Nasdaq delisting notice - Stock Titan
GeoVax Labs (NASDAQ: GOVX) Secures $3.65M from Warrant Exercise, Issues 11.4M New Warrants at $0.64 - Kalkine Media
GeoVax Labs Inc. Warrants (GOVXW) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
GeoVax Labs (GOVX) Holds Near $0.72 as Stock Consolidates Within Key Trading RangeInitial Balance - dars.gov.et
GeoVax Raises $3.6M in Warrant Inducement, Issues 11.4M New Warrants - Minichart
GeoVax Raises $3.65M Via Warrant Exercise, Issues 11.4M New Warrants at $0.64 - TradingView
GeoVax Labs (GOVX) swaps $3.6M now for future warrant upside - Stock Titan
GeoVax Labs Inc. (GOVX) Peer Comparison – Compare with Others - Value Research
GeoVax Labs Inc. (GOVX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
GeoVax Announces a Warrant Inducement Transaction - Yahoo Finance
GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation - Yahoo Finance
GeoVax Initiates Global Health Outreach to WHO, Africa CDC and Other Agencies Regarding Ebola Vaccine Portfolio Amid Expanding Outbreak - Yahoo Finance
GeoVax (GOVX) Quarterly Figures: EPS Lands Above Forecast; Post-Report: Shares Close 7.31% Higher in the Latest SessionSlow Growth Warning - vinanet.vn
GOVX Should I Buy - intellectia.ai
Why Is GOVX Stock Falling Today? - Stocktwits
GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit - Yahoo Finance
GeoVax (GOVX) Financial Results: The Available Earnings Metric Delivers a Beat at the Close; Price Move: Shares Move 0.86% DownRevenue Estimate Trend - vinanet.vn
GeoVax Labs (GOVX): Armistice Capital and Steven Boyd disclose 4.99% stake - Stock Titan
GeoVax Labs (GOVX) holders report 1.59% stake tied to 118,715 warrants - Stock Titan
GeoVax Highlights Capabilities Amid Congo's Expanding Ebola Outbreak - Yahoo Finance
GeoVax Labs, Inc. (GOVX) holders cap ownership at 4.99% with warrants - Stock Titan
GOVX: GEO-MVA targets a $1.3B vaccine market gap with expedited approval and scalable U.S. supply - TradingView
GeoVax Labs (GOVX) Dips 3.38% to $0.74, Holding Above Key $0.70 SupportDaily Profile - Vinanet
GeoVax Labs (NASDAQ:GOVX): What Could Today’s program progress and financing needs Update Reveal? - Kalkine Media
GeoVax Labs, Inc. (GOVX) Stock Price, News, Quote & History - Yahoo! Finance Canada
GeoVax targets Q4 phase 3 trial for MVA mpox vaccine with EMA expedited pathway - Proactive financial news
GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase - Yahoo Finance
GeoVax Labs (GOVX) Dips 2.07% to $0.75 as Biotech Tests Key SupportConversion Trade - dars.gov.et
Jane Street Group discloses 4.3% GeoVax Labs (GOVX) ownership in updated 13G - Stock Titan
Health preparedness key as biological threats evolve - BioProcess International
GOVX Q2 2026 Earnings: Loss Narrower Than Expected Despite No RevenueBasic EPS Analysis - vinanet.vn
GOVX Q2 2026 Earnings: 66.98% EPS Surprise Lifts Shares 6.75%Post-Earnings Reaction - vinanet.vn
GeoVax Completes Key Milestones for GEO-MVA, Paving Way for Phase 3 Trial - citybuzz -
GeoVax Announces Completion of Key GEO-MVA Development Milestones, Positioning Program for Pivotal Phase 3 Clinical Study - Yahoo Finance
GeoVax Highlights Newly Published Independent Research Supporting Broader Filovirus Vaccine Strategies and Strategic Value of Its MVA-Based Vaccine Portfolio - Yahoo Finance
GeoVax Labs (GOVX) Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.97 Per ShareOne-Time Loss Impact - vinanet.vn
GeoVax Labs Inc (GOVX) Institutional Confidence - TradingKey
GOVX Q2 2026 Earnings: EPS Surprises Positively Despite Revenue AbsenceReturn On Assets - vinanet.vn
GOVX Q2 2026 Earnings: Narrower-than-expected loss highlights cost discipline amid developmental stageRevenue Inflection Point - vinanet.vn
GeoVax Labs (GOVX) Drops 6.82% as Biotech Stock Tests Key Support LevelsTotal Put Call - vinanet.vn
GeoVax Labs Inc (GOVX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Geovax Labs Market Sentiment - Benzinga España
GeoVax Labs, Inc. 2026 Q2 Financial Report: Earnings, Losses & Key Financial Statements Overview - Minichart
GeoVax Advances GEO-MVA Pivotal Study Amid Strategic Reprioritization - citybuzz -
GeoVax Labs, Inc. Reports Q2 2026 Financial Results and Advances in Immuno-Oncology Programs - Minichart
GEOVAX LABS ($GOVX) Releases Q2 2026 Earnings - Quiver Quantitative
Geovax Labs Inc Azioni (GOVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):